Global Nasal Spray Live Attenuated Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Global Nasal Spray Live Attenuated Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 107

Published Date: 19 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Nasal Spray Live Attenuated Influenza Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Nasal Spray Live Attenuated Influenza Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Nasal Spray Live Attenuated Influenza Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nasal Spray Live Attenuated Influenza Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Nasal Spray Live Attenuated Influenza Vaccine total production and demand, 2018-2029, (K Units)
Global Nasal Spray Live Attenuated Influenza Vaccine total production value, 2018-2029, (USD Million)
Global Nasal Spray Live Attenuated Influenza Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nasal Spray Live Attenuated Influenza Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Nasal Spray Live Attenuated Influenza Vaccine domestic production, consumption, key domestic manufacturers and share
Global Nasal Spray Live Attenuated Influenza Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Nasal Spray Live Attenuated Influenza Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nasal Spray Live Attenuated Influenza Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Nasal Spray Live Attenuated Influenza Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, AstraZeneca, CSL, Abbott, GlaxoSmithKline, Serum Institute, Fluenz Tetra, BioDiem and FluMist, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nasal Spray Live Attenuated Influenza Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Nasal Spray Live Attenuated Influenza Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Nasal Spray Live Attenuated Influenza Vaccine Market, Segmentation by Type
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine

Global Nasal Spray Live Attenuated Influenza Vaccine Market, Segmentation by Application
Hospital
Clinic
Public Health Agency
Other

Companies Profiled:
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline
Serum Institute
Fluenz Tetra
BioDiem
FluMist
ChangChun High & New Technology
BCHT Biotechnology

Key Questions Answered
1. How big is the global Nasal Spray Live Attenuated Influenza Vaccine market?
2. What is the demand of the global Nasal Spray Live Attenuated Influenza Vaccine market?
3. What is the year over year growth of the global Nasal Spray Live Attenuated Influenza Vaccine market?
4. What is the production and production value of the global Nasal Spray Live Attenuated Influenza Vaccine market?
5. Who are the key producers in the global Nasal Spray Live Attenuated Influenza Vaccine market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Nasal Spray Live Attenuated Influenza Vaccine Introduction
1.2 World Nasal Spray Live Attenuated Influenza Vaccine Supply & Forecast
1.2.1 World Nasal Spray Live Attenuated Influenza Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029)
1.2.3 World Nasal Spray Live Attenuated Influenza Vaccine Pricing Trends (2018-2029)
1.3 World Nasal Spray Live Attenuated Influenza Vaccine Production by Region (Based on Production Site)
1.3.1 World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Region (2018-2029)
1.3.2 World Nasal Spray Live Attenuated Influenza Vaccine Production by Region (2018-2029)
1.3.3 World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Region (2018-2029)
1.3.4 North America Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029)
1.3.5 Europe Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029)
1.3.6 China Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029)
1.3.7 Japan Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nasal Spray Live Attenuated Influenza Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nasal Spray Live Attenuated Influenza Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Nasal Spray Live Attenuated Influenza Vaccine Demand (2018-2029)
2.2 World Nasal Spray Live Attenuated Influenza Vaccine Consumption by Region
2.2.1 World Nasal Spray Live Attenuated Influenza Vaccine Consumption by Region (2018-2023)
2.2.2 World Nasal Spray Live Attenuated Influenza Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)
2.4 China Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)
2.5 Europe Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)
2.6 Japan Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)
2.7 South Korea Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)
2.8 ASEAN Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)
2.9 India Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)

3 World Nasal Spray Live Attenuated Influenza Vaccine Manufacturers Competitive Analysis
3.1 World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Nasal Spray Live Attenuated Influenza Vaccine Production by Manufacturer (2018-2023)
3.3 World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Nasal Spray Live Attenuated Influenza Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nasal Spray Live Attenuated Influenza Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nasal Spray Live Attenuated Influenza Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Nasal Spray Live Attenuated Influenza Vaccine in 2022
3.6 Nasal Spray Live Attenuated Influenza Vaccine Market: Overall Company Footprint Analysis
3.6.1 Nasal Spray Live Attenuated Influenza Vaccine Market: Region Footprint
3.6.2 Nasal Spray Live Attenuated Influenza Vaccine Market: Company Product Type Footprint
3.6.3 Nasal Spray Live Attenuated Influenza Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Value Comparison
4.1.1 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Comparison
4.2.1 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Consumption Comparison
4.3.1 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2023)
4.5 China Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers and Market Share
4.5.1 China Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2023)
4.6 Rest of World Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2023)

5 Market Analysis by Type
5.1 World Nasal Spray Live Attenuated Influenza Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Trivalent Flu Vaccine
5.2.2 Quadrivalent Flu Vaccine
5.3 Market Segment by Type
5.3.1 World Nasal Spray Live Attenuated Influenza Vaccine Production by Type (2018-2029)
5.3.2 World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Type (2018-2029)
5.3.3 World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Nasal Spray Live Attenuated Influenza Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Public Health Agency
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Nasal Spray Live Attenuated Influenza Vaccine Production by Application (2018-2029)
6.3.2 World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Application (2018-2029)
6.3.3 World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Application (2018-2029)

7 Company Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Details
7.1.2 Sanofi Pasteur Major Business
7.1.3 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.1.4 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Pasteur Recent Developments/Updates
7.1.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.2.4 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 CSL
7.3.1 CSL Details
7.3.2 CSL Major Business
7.3.3 CSL Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.3.4 CSL Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 CSL Recent Developments/Updates
7.3.6 CSL Competitive Strengths & Weaknesses
7.4 Abbott
7.4.1 Abbott Details
7.4.2 Abbott Major Business
7.4.3 Abbott Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.4.4 Abbott Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Abbott Recent Developments/Updates
7.4.6 Abbott Competitive Strengths & Weaknesses
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Details
7.5.2 GlaxoSmithKline Major Business
7.5.3 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.5.4 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GlaxoSmithKline Recent Developments/Updates
7.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.6 Serum Institute
7.6.1 Serum Institute Details
7.6.2 Serum Institute Major Business
7.6.3 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.6.4 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Serum Institute Recent Developments/Updates
7.6.6 Serum Institute Competitive Strengths & Weaknesses
7.7 Fluenz Tetra
7.7.1 Fluenz Tetra Details
7.7.2 Fluenz Tetra Major Business
7.7.3 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.7.4 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Fluenz Tetra Recent Developments/Updates
7.7.6 Fluenz Tetra Competitive Strengths & Weaknesses
7.8 BioDiem
7.8.1 BioDiem Details
7.8.2 BioDiem Major Business
7.8.3 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.8.4 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 BioDiem Recent Developments/Updates
7.8.6 BioDiem Competitive Strengths & Weaknesses
7.9 FluMist
7.9.1 FluMist Details
7.9.2 FluMist Major Business
7.9.3 FluMist Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.9.4 FluMist Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 FluMist Recent Developments/Updates
7.9.6 FluMist Competitive Strengths & Weaknesses
7.10 ChangChun High & New Technology
7.10.1 ChangChun High & New Technology Details
7.10.2 ChangChun High & New Technology Major Business
7.10.3 ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.10.4 ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 ChangChun High & New Technology Recent Developments/Updates
7.10.6 ChangChun High & New Technology Competitive Strengths & Weaknesses
7.11 BCHT Biotechnology
7.11.1 BCHT Biotechnology Details
7.11.2 BCHT Biotechnology Major Business
7.11.3 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.11.4 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 BCHT Biotechnology Recent Developments/Updates
7.11.6 BCHT Biotechnology Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Nasal Spray Live Attenuated Influenza Vaccine Industry Chain
8.2 Nasal Spray Live Attenuated Influenza Vaccine Upstream Analysis
8.2.1 Nasal Spray Live Attenuated Influenza Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Nasal Spray Live Attenuated Influenza Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nasal Spray Live Attenuated Influenza Vaccine Production Mode
8.6 Nasal Spray Live Attenuated Influenza Vaccine Procurement Model
8.7 Nasal Spray Live Attenuated Influenza Vaccine Industry Sales Model and Sales Channels
8.7.1 Nasal Spray Live Attenuated Influenza Vaccine Sales Model
8.7.2 Nasal Spray Live Attenuated Influenza Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Nasal Spray Live Attenuated Influenza Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Nasal Spray Live Attenuated Influenza Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Nasal Spray Live Attenuated Influenza Vaccine Production Market Share by Region (2018-2023)
Table 9. World Nasal Spray Live Attenuated Influenza Vaccine Production Market Share by Region (2024-2029)
Table 10. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nasal Spray Live Attenuated Influenza Vaccine Major Market Trends
Table 13. World Nasal Spray Live Attenuated Influenza Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Nasal Spray Live Attenuated Influenza Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Nasal Spray Live Attenuated Influenza Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nasal Spray Live Attenuated Influenza Vaccine Producers in 2022
Table 18. World Nasal Spray Live Attenuated Influenza Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Nasal Spray Live Attenuated Influenza Vaccine Producers in 2022
Table 20. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nasal Spray Live Attenuated Influenza Vaccine Company Evaluation Quadrant
Table 22. World Nasal Spray Live Attenuated Influenza Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nasal Spray Live Attenuated Influenza Vaccine Production Site of Key Manufacturer
Table 24. Nasal Spray Live Attenuated Influenza Vaccine Market: Company Product Type Footprint
Table 25. Nasal Spray Live Attenuated Influenza Vaccine Market: Company Product Application Footprint
Table 26. Nasal Spray Live Attenuated Influenza Vaccine Competitive Factors
Table 27. Nasal Spray Live Attenuated Influenza Vaccine New Entrant and Capacity Expansion Plans
Table 28. Nasal Spray Live Attenuated Influenza Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Nasal Spray Live Attenuated Influenza Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nasal Spray Live Attenuated Influenza Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Nasal Spray Live Attenuated Influenza Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Market Share (2018-2023)
Table 37. China Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Market Share (2018-2023)
Table 47. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nasal Spray Live Attenuated Influenza Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Nasal Spray Live Attenuated Influenza Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nasal Spray Live Attenuated Influenza Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Nasal Spray Live Attenuated Influenza Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Pasteur Major Business
Table 63. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 64. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Pasteur Recent Developments/Updates
Table 66. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 70. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. CSL Basic Information, Manufacturing Base and Competitors
Table 74. CSL Major Business
Table 75. CSL Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 76. CSL Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. CSL Recent Developments/Updates
Table 78. CSL Competitive Strengths & Weaknesses
Table 79. Abbott Basic Information, Manufacturing Base and Competitors
Table 80. Abbott Major Business
Table 81. Abbott Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 82. Abbott Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Abbott Recent Developments/Updates
Table 84. Abbott Competitive Strengths & Weaknesses
Table 85. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 86. GlaxoSmithKline Major Business
Table 87. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 88. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 91. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 92. Serum Institute Major Business
Table 93. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 94. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Serum Institute Recent Developments/Updates
Table 96. Serum Institute Competitive Strengths & Weaknesses
Table 97. Fluenz Tetra Basic Information, Manufacturing Base and Competitors
Table 98. Fluenz Tetra Major Business
Table 99. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 100. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Fluenz Tetra Recent Developments/Updates
Table 102. Fluenz Tetra Competitive Strengths & Weaknesses
Table 103. BioDiem Basic Information, Manufacturing Base and Competitors
Table 104. BioDiem Major Business
Table 105. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 106. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. BioDiem Recent Developments/Updates
Table 108. BioDiem Competitive Strengths & Weaknesses
Table 109. FluMist Basic Information, Manufacturing Base and Competitors
Table 110. FluMist Major Business
Table 111. FluMist Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 112. FluMist Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. FluMist Recent Developments/Updates
Table 114. FluMist Competitive Strengths & Weaknesses
Table 115. ChangChun High & New Technology Basic Information, Manufacturing Base and Competitors
Table 116. ChangChun High & New Technology Major Business
Table 117. ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 118. ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. ChangChun High & New Technology Recent Developments/Updates
Table 120. BCHT Biotechnology Basic Information, Manufacturing Base and Competitors
Table 121. BCHT Biotechnology Major Business
Table 122. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 123. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Nasal Spray Live Attenuated Influenza Vaccine Upstream (Raw Materials)
Table 125. Nasal Spray Live Attenuated Influenza Vaccine Typical Customers
Table 126. Nasal Spray Live Attenuated Influenza Vaccine Typical Distributors
List of Figure
Figure 1. Nasal Spray Live Attenuated Influenza Vaccine Picture
Figure 2. World Nasal Spray Live Attenuated Influenza Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nasal Spray Live Attenuated Influenza Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029) & (K Units)
Figure 5. World Nasal Spray Live Attenuated Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Nasal Spray Live Attenuated Influenza Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029) & (K Units)
Figure 10. China Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029) & (K Units)
Figure 12. Nasal Spray Live Attenuated Influenza Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Nasal Spray Live Attenuated Influenza Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Nasal Spray Live Attenuated Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nasal Spray Live Attenuated Influenza Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nasal Spray Live Attenuated Influenza Vaccine Markets in 2022
Figure 26. United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Market Share 2022
Figure 32. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Type in 2022
Figure 34. Trivalent Flu Vaccine
Figure 35. Quadrivalent Flu Vaccine
Figure 36. World Nasal Spray Live Attenuated Influenza Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Public Health Agency
Figure 44. Other
Figure 45. World Nasal Spray Live Attenuated Influenza Vaccine Production Market Share by Application (2018-2029)
Figure 46. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Application (2018-2029)
Figure 47. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Nasal Spray Live Attenuated Influenza Vaccine Industry Chain
Figure 49. Nasal Spray Live Attenuated Influenza Vaccine Procurement Model
Figure 50. Nasal Spray Live Attenuated Influenza Vaccine Sales Model
Figure 51. Nasal Spray Live Attenuated Influenza Vaccine Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Nasal Spray Live Attenuated Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Global Nasal Spray Live Attenuated Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 107

Published Date: 19 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Nasal Spray Live Attenuated Influenza Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Nasal Spray Live Attenuated Influenza Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Nasal Spray Live Attenuated Influenza Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nasal Spray Live Attenuated Influenza Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Nasal Spray Live Attenuated Influenza Vaccine total production and demand, 2018-2029, (K Units)
Global Nasal Spray Live Attenuated Influenza Vaccine total production value, 2018-2029, (USD Million)
Global Nasal Spray Live Attenuated Influenza Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nasal Spray Live Attenuated Influenza Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Nasal Spray Live Attenuated Influenza Vaccine domestic production, consumption, key domestic manufacturers and share
Global Nasal Spray Live Attenuated Influenza Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Nasal Spray Live Attenuated Influenza Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nasal Spray Live Attenuated Influenza Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Nasal Spray Live Attenuated Influenza Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, AstraZeneca, CSL, Abbott, GlaxoSmithKline, Serum Institute, Fluenz Tetra, BioDiem and FluMist, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nasal Spray Live Attenuated Influenza Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Nasal Spray Live Attenuated Influenza Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Nasal Spray Live Attenuated Influenza Vaccine Market, Segmentation by Type
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine

Global Nasal Spray Live Attenuated Influenza Vaccine Market, Segmentation by Application
Hospital
Clinic
Public Health Agency
Other

Companies Profiled:
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline
Serum Institute
Fluenz Tetra
BioDiem
FluMist
ChangChun High & New Technology
BCHT Biotechnology

Key Questions Answered
1. How big is the global Nasal Spray Live Attenuated Influenza Vaccine market?
2. What is the demand of the global Nasal Spray Live Attenuated Influenza Vaccine market?
3. What is the year over year growth of the global Nasal Spray Live Attenuated Influenza Vaccine market?
4. What is the production and production value of the global Nasal Spray Live Attenuated Influenza Vaccine market?
5. Who are the key producers in the global Nasal Spray Live Attenuated Influenza Vaccine market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Nasal Spray Live Attenuated Influenza Vaccine Introduction
1.2 World Nasal Spray Live Attenuated Influenza Vaccine Supply & Forecast
1.2.1 World Nasal Spray Live Attenuated Influenza Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029)
1.2.3 World Nasal Spray Live Attenuated Influenza Vaccine Pricing Trends (2018-2029)
1.3 World Nasal Spray Live Attenuated Influenza Vaccine Production by Region (Based on Production Site)
1.3.1 World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Region (2018-2029)
1.3.2 World Nasal Spray Live Attenuated Influenza Vaccine Production by Region (2018-2029)
1.3.3 World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Region (2018-2029)
1.3.4 North America Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029)
1.3.5 Europe Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029)
1.3.6 China Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029)
1.3.7 Japan Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nasal Spray Live Attenuated Influenza Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nasal Spray Live Attenuated Influenza Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Nasal Spray Live Attenuated Influenza Vaccine Demand (2018-2029)
2.2 World Nasal Spray Live Attenuated Influenza Vaccine Consumption by Region
2.2.1 World Nasal Spray Live Attenuated Influenza Vaccine Consumption by Region (2018-2023)
2.2.2 World Nasal Spray Live Attenuated Influenza Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)
2.4 China Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)
2.5 Europe Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)
2.6 Japan Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)
2.7 South Korea Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)
2.8 ASEAN Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)
2.9 India Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029)

3 World Nasal Spray Live Attenuated Influenza Vaccine Manufacturers Competitive Analysis
3.1 World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Nasal Spray Live Attenuated Influenza Vaccine Production by Manufacturer (2018-2023)
3.3 World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Nasal Spray Live Attenuated Influenza Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nasal Spray Live Attenuated Influenza Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nasal Spray Live Attenuated Influenza Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Nasal Spray Live Attenuated Influenza Vaccine in 2022
3.6 Nasal Spray Live Attenuated Influenza Vaccine Market: Overall Company Footprint Analysis
3.6.1 Nasal Spray Live Attenuated Influenza Vaccine Market: Region Footprint
3.6.2 Nasal Spray Live Attenuated Influenza Vaccine Market: Company Product Type Footprint
3.6.3 Nasal Spray Live Attenuated Influenza Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Value Comparison
4.1.1 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Comparison
4.2.1 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Consumption Comparison
4.3.1 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2023)
4.5 China Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers and Market Share
4.5.1 China Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2023)
4.6 Rest of World Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2023)

5 Market Analysis by Type
5.1 World Nasal Spray Live Attenuated Influenza Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Trivalent Flu Vaccine
5.2.2 Quadrivalent Flu Vaccine
5.3 Market Segment by Type
5.3.1 World Nasal Spray Live Attenuated Influenza Vaccine Production by Type (2018-2029)
5.3.2 World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Type (2018-2029)
5.3.3 World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Nasal Spray Live Attenuated Influenza Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Public Health Agency
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Nasal Spray Live Attenuated Influenza Vaccine Production by Application (2018-2029)
6.3.2 World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Application (2018-2029)
6.3.3 World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Application (2018-2029)

7 Company Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Details
7.1.2 Sanofi Pasteur Major Business
7.1.3 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.1.4 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Pasteur Recent Developments/Updates
7.1.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.2.4 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 CSL
7.3.1 CSL Details
7.3.2 CSL Major Business
7.3.3 CSL Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.3.4 CSL Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 CSL Recent Developments/Updates
7.3.6 CSL Competitive Strengths & Weaknesses
7.4 Abbott
7.4.1 Abbott Details
7.4.2 Abbott Major Business
7.4.3 Abbott Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.4.4 Abbott Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Abbott Recent Developments/Updates
7.4.6 Abbott Competitive Strengths & Weaknesses
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Details
7.5.2 GlaxoSmithKline Major Business
7.5.3 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.5.4 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GlaxoSmithKline Recent Developments/Updates
7.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.6 Serum Institute
7.6.1 Serum Institute Details
7.6.2 Serum Institute Major Business
7.6.3 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.6.4 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Serum Institute Recent Developments/Updates
7.6.6 Serum Institute Competitive Strengths & Weaknesses
7.7 Fluenz Tetra
7.7.1 Fluenz Tetra Details
7.7.2 Fluenz Tetra Major Business
7.7.3 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.7.4 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Fluenz Tetra Recent Developments/Updates
7.7.6 Fluenz Tetra Competitive Strengths & Weaknesses
7.8 BioDiem
7.8.1 BioDiem Details
7.8.2 BioDiem Major Business
7.8.3 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.8.4 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 BioDiem Recent Developments/Updates
7.8.6 BioDiem Competitive Strengths & Weaknesses
7.9 FluMist
7.9.1 FluMist Details
7.9.2 FluMist Major Business
7.9.3 FluMist Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.9.4 FluMist Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 FluMist Recent Developments/Updates
7.9.6 FluMist Competitive Strengths & Weaknesses
7.10 ChangChun High & New Technology
7.10.1 ChangChun High & New Technology Details
7.10.2 ChangChun High & New Technology Major Business
7.10.3 ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.10.4 ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 ChangChun High & New Technology Recent Developments/Updates
7.10.6 ChangChun High & New Technology Competitive Strengths & Weaknesses
7.11 BCHT Biotechnology
7.11.1 BCHT Biotechnology Details
7.11.2 BCHT Biotechnology Major Business
7.11.3 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product and Services
7.11.4 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 BCHT Biotechnology Recent Developments/Updates
7.11.6 BCHT Biotechnology Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Nasal Spray Live Attenuated Influenza Vaccine Industry Chain
8.2 Nasal Spray Live Attenuated Influenza Vaccine Upstream Analysis
8.2.1 Nasal Spray Live Attenuated Influenza Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Nasal Spray Live Attenuated Influenza Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nasal Spray Live Attenuated Influenza Vaccine Production Mode
8.6 Nasal Spray Live Attenuated Influenza Vaccine Procurement Model
8.7 Nasal Spray Live Attenuated Influenza Vaccine Industry Sales Model and Sales Channels
8.7.1 Nasal Spray Live Attenuated Influenza Vaccine Sales Model
8.7.2 Nasal Spray Live Attenuated Influenza Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Nasal Spray Live Attenuated Influenza Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Nasal Spray Live Attenuated Influenza Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Nasal Spray Live Attenuated Influenza Vaccine Production Market Share by Region (2018-2023)
Table 9. World Nasal Spray Live Attenuated Influenza Vaccine Production Market Share by Region (2024-2029)
Table 10. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nasal Spray Live Attenuated Influenza Vaccine Major Market Trends
Table 13. World Nasal Spray Live Attenuated Influenza Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Nasal Spray Live Attenuated Influenza Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Nasal Spray Live Attenuated Influenza Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nasal Spray Live Attenuated Influenza Vaccine Producers in 2022
Table 18. World Nasal Spray Live Attenuated Influenza Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Nasal Spray Live Attenuated Influenza Vaccine Producers in 2022
Table 20. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nasal Spray Live Attenuated Influenza Vaccine Company Evaluation Quadrant
Table 22. World Nasal Spray Live Attenuated Influenza Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nasal Spray Live Attenuated Influenza Vaccine Production Site of Key Manufacturer
Table 24. Nasal Spray Live Attenuated Influenza Vaccine Market: Company Product Type Footprint
Table 25. Nasal Spray Live Attenuated Influenza Vaccine Market: Company Product Application Footprint
Table 26. Nasal Spray Live Attenuated Influenza Vaccine Competitive Factors
Table 27. Nasal Spray Live Attenuated Influenza Vaccine New Entrant and Capacity Expansion Plans
Table 28. Nasal Spray Live Attenuated Influenza Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Nasal Spray Live Attenuated Influenza Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nasal Spray Live Attenuated Influenza Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Nasal Spray Live Attenuated Influenza Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Market Share (2018-2023)
Table 37. China Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Nasal Spray Live Attenuated Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Market Share (2018-2023)
Table 47. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nasal Spray Live Attenuated Influenza Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Nasal Spray Live Attenuated Influenza Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nasal Spray Live Attenuated Influenza Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Nasal Spray Live Attenuated Influenza Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Pasteur Major Business
Table 63. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 64. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Pasteur Recent Developments/Updates
Table 66. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 70. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. CSL Basic Information, Manufacturing Base and Competitors
Table 74. CSL Major Business
Table 75. CSL Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 76. CSL Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. CSL Recent Developments/Updates
Table 78. CSL Competitive Strengths & Weaknesses
Table 79. Abbott Basic Information, Manufacturing Base and Competitors
Table 80. Abbott Major Business
Table 81. Abbott Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 82. Abbott Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Abbott Recent Developments/Updates
Table 84. Abbott Competitive Strengths & Weaknesses
Table 85. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 86. GlaxoSmithKline Major Business
Table 87. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 88. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 91. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 92. Serum Institute Major Business
Table 93. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 94. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Serum Institute Recent Developments/Updates
Table 96. Serum Institute Competitive Strengths & Weaknesses
Table 97. Fluenz Tetra Basic Information, Manufacturing Base and Competitors
Table 98. Fluenz Tetra Major Business
Table 99. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 100. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Fluenz Tetra Recent Developments/Updates
Table 102. Fluenz Tetra Competitive Strengths & Weaknesses
Table 103. BioDiem Basic Information, Manufacturing Base and Competitors
Table 104. BioDiem Major Business
Table 105. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 106. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. BioDiem Recent Developments/Updates
Table 108. BioDiem Competitive Strengths & Weaknesses
Table 109. FluMist Basic Information, Manufacturing Base and Competitors
Table 110. FluMist Major Business
Table 111. FluMist Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 112. FluMist Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. FluMist Recent Developments/Updates
Table 114. FluMist Competitive Strengths & Weaknesses
Table 115. ChangChun High & New Technology Basic Information, Manufacturing Base and Competitors
Table 116. ChangChun High & New Technology Major Business
Table 117. ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 118. ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. ChangChun High & New Technology Recent Developments/Updates
Table 120. BCHT Biotechnology Basic Information, Manufacturing Base and Competitors
Table 121. BCHT Biotechnology Major Business
Table 122. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product and Services
Table 123. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Nasal Spray Live Attenuated Influenza Vaccine Upstream (Raw Materials)
Table 125. Nasal Spray Live Attenuated Influenza Vaccine Typical Customers
Table 126. Nasal Spray Live Attenuated Influenza Vaccine Typical Distributors
List of Figure
Figure 1. Nasal Spray Live Attenuated Influenza Vaccine Picture
Figure 2. World Nasal Spray Live Attenuated Influenza Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nasal Spray Live Attenuated Influenza Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029) & (K Units)
Figure 5. World Nasal Spray Live Attenuated Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Nasal Spray Live Attenuated Influenza Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029) & (K Units)
Figure 10. China Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Nasal Spray Live Attenuated Influenza Vaccine Production (2018-2029) & (K Units)
Figure 12. Nasal Spray Live Attenuated Influenza Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Nasal Spray Live Attenuated Influenza Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Nasal Spray Live Attenuated Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Nasal Spray Live Attenuated Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nasal Spray Live Attenuated Influenza Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nasal Spray Live Attenuated Influenza Vaccine Markets in 2022
Figure 26. United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nasal Spray Live Attenuated Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Production Market Share 2022
Figure 32. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Type in 2022
Figure 34. Trivalent Flu Vaccine
Figure 35. Quadrivalent Flu Vaccine
Figure 36. World Nasal Spray Live Attenuated Influenza Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Nasal Spray Live Attenuated Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Public Health Agency
Figure 44. Other
Figure 45. World Nasal Spray Live Attenuated Influenza Vaccine Production Market Share by Application (2018-2029)
Figure 46. World Nasal Spray Live Attenuated Influenza Vaccine Production Value Market Share by Application (2018-2029)
Figure 47. World Nasal Spray Live Attenuated Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Nasal Spray Live Attenuated Influenza Vaccine Industry Chain
Figure 49. Nasal Spray Live Attenuated Influenza Vaccine Procurement Model
Figure 50. Nasal Spray Live Attenuated Influenza Vaccine Sales Model
Figure 51. Nasal Spray Live Attenuated Influenza Vaccine Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

jiaGou

Add To Cart

gouMai

Buy Now